MedFirst Healthcare Services, Inc. (TPEX:4175)
Taiwan · Delayed Price · Currency is TWD 55.50
+0.10 (0.18%)
Apr 20, 2026, 12:59 PM CST
TPEX:4175 Revenue
In the year 2025, MedFirst Healthcare Services had annual revenue of 8.01B TWD with 3.60% growth. MedFirst Healthcare Services had revenue of 2.11B in the quarter ending December 31, 2025, with 3.29% growth.
Revenue
8.01B
Revenue Growth
+3.60%
P/S Ratio
0.29
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.01B | 278.57M | 3.60% |
| Dec 31, 2024 | 7.73B | 287.90M | 3.87% |
| Dec 31, 2023 | 7.45B | 222.11M | 3.07% |
| Dec 31, 2022 | 7.22B | 683.79M | 10.46% |
| Dec 31, 2021 | 6.54B | 612.84M | 10.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lotus Pharmaceutical | 20.51B |
| PharmaEssentia | 15.63B |
| Wellell | 2.40B |
| A Plus Biotechnology | 835.89M |
| Chunghwa Chemical Synthesis & Biotech | 804.88M |
| Johnson Chemical Pharmaceutical Works | 569.77M |
| Applied BioCode | 475.20M |
| G&E Herbal Biotechnology | 309.13M |